Cancer care pathways across seven countries in Europe: What are the current obstacles? And how can artificial intelligence help?

Journal: Journal of cancer policy
PMID:

Abstract

BACKGROUND: Cancer poses significant challenges for healthcare professionals across the disease pathway including cancer imaging. This study constitutes part of the user requirement definition of INCISIVE EU project. The project has been designed to explore the full potential of artificial intelligence (AI)-based technologies in cancer imaging to streamline diagnosis and management. The study aimed to map cancer care pathways (breast, prostate, colorectal and lung cancers) across INCISIVE partner countries, and identify bottle necks within these pathways.

Authors

  • Iman Hesso
    School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom.
  • Reem Kayyali
    School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom.
  • Lithin Zacharias
    School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom.
  • Andreas Charalambous
    Associate Professor, Oncology and Palliative Care, Cyprus University of Technology, Osijek, Croatia. Electronic address: andreas.charalambous@cut.ac.cy.
  • Maria Lavdaniti
    International Hellenic University, Thessaloniki, Greece.
  • Evangelia Stalika
    International Hellenic University, Thessaloniki, Greece; Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Tarek Ajami
    Kidney Transplant Unit. Urology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
  • Wanda Acampa
    Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy.
  • Jasmina Boban
    Department of Radiology, Faculty of Medicine, University of Novi Sad, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; Diagnostic Imaging Center, Oncology Institute of Vojvodine, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
  • Shereen Nabhani Gebara
    School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston upon Thames, United Kingdom. Electronic address: S.Nabhani@kingston.ac.uk.